Fundz

Lakefront Biotherapeutics Appoints Eric Hedrick as Chief Medical Officer

PUBLIC · LKFTJun 08, 2026

Position

Chief Medical Officer

Company

Lakefront Biotherapeutics NV

Eric Hedrick
MechelenBiotechnologyHealth CareTherapeuticsBiopharma

Description

Lakefront Biotherapeutics NV has appointed Eric Hedrick, MD, as its new Chief Medical Officer. This position expands leadership in line with the company’s strategic transformation following a recent acquisition.

Quick answer

Lakefront Biotherapeutics Appoints Eric Hedrick as Chief Medical Officer (June 8, 2026). Lakefront Biotherapeutics NV is based in Mechelen, Antwerp, Belgium.

Who is the new Chief Medical Officer at Lakefront Biotherapeutics NV?
Lakefront Biotherapeutics NV named Eric Hedrick Chief Medical Officer, announced June 8, 2026.
What did Lakefront Biotherapeutics NV announce on June 8, 2026?
Lakefront Biotherapeutics NV has appointed Eric Hedrick, MD, as its new Chief Medical Officer. This position expands leadership in line with the company’s strategic transformation following a recent acquisition.
What does Lakefront Biotherapeutics NV do?
Lakefront Biotherapeutics is a biotechnology company focused on developing innovative immunotherapy treatments.
Where is Lakefront Biotherapeutics NV based?
Lakefront Biotherapeutics NV is based in Mechelen, Antwerp, Belgium.

Source: Fundz verified event record.

Who to call at Lakefront Biotherapeutics NV, and when

A new leader at Lakefront Biotherapeutics NV brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Lakefront Biotherapeutics NV raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lakefront Biotherapeutics NV, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lakefront Biotherapeutics NV. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lakefront Biotherapeutics NV

Location

Mechelen, Antwerp, Belgium

About

Lakefront Biotherapeutics is a biotechnology company focused on developing innovative immunotherapy treatments. They leverage unique technologies to create potential first-in-class therapies for autoimmune diseases. The company aims to deliver significant breakthroughs in patient care through advanced research and clinical trials.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lakefront Biotherapeutics NV changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Lakefront Biotherapeutics NV's next move

Learn about Strategic plan

Lakefront Biotherapeutics NV changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.